Clinical study on the treatment of chronic obstructive pulmonary disease group D in stable stage with integrated traditional Chinese and Western Medicine

Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Aged 50-75 years;
•2. Meet the diagnostic criteria for stable chronic obstructive pulmonary disease in Western medicine;
•3. Meet the diagnostic criteria of TCM syndrome of yang deficiency and blood stasis and phlegm turbidity in the lung;
•4. Acute exacerbation >= 2 times or >= 1 time leading to hospitalization in 1 year;
•5. mMRC grade >= 2;
•6. Exclude other lung diseases and lung diseases caused by other systemic diseases;
•7. Agree to participate in clinical observation and be able to receive treatment and various examinations, and sign the informed consent.

•1. Asymptomatic or only pulmonary function test FEV1/FVC<0.70;
•2. Suffering from severe cardiovascular disease, central nervous system disease, liver and kidney insufficiency, history of gastrointestinal bleeding, severe diabetes, malignant tumor and other diseases;
•3. Patients with anxiety, depression and other mental illnesses;
•4. Allergic constitution and allergic to the test drug;
•5. Those who cannot take the medicine on time and are not expected to complete the 6-month treatment and follow-up;
•6. Patients who are participating in other clinical trials.

发起方

Hospital of Chengdu University of Traditional Chinese Medicine